• Rezolve AI PLC recently raised its revenue guidance, now expecting at least US$40,000,000 for 2025 and approximately US$350,000,000 for 2026, well above prior analyst and market expectations.
• This very large planned step-up in revenue, outlined shortly after Rezolve AI’s NRF 2026 retail conference presentations, signals a materially more ambitious growth path than the market had been anticipating.
• We’ll now look at how Rezolve AI’s significantly higher 2025 and 2026 revenue guidance reshapes the company’s investment narrative and risk profile.

These 16 companies survived and thrived after COVID and have the right ingredients to survive Trump's tariffs. Discover why before your portfolio feels the trade war pinch.

What Is Rezolve AI's Investment Narrative?

To own Rezolve AI today, you have to believe its Agentic Commerce vision, new retail-focused products and recent high-profile hires can convert early traction into a much larger, defensible revenue base, despite ongoing losses and heavy dilution. The new guidance of at least US$40,000,000 revenue in 2025 and roughly US$350,000,000 in 2026 materially raises the bar for execution and helps explain the sharp short-term share price reaction, but it also amplifies near-term delivery risk. Key catalysts now include evidence that December’s “strongest month” revenue run-rate is sustainable, further enterprise wins stemming from the NRF 2026 presence, and disciplined use of the sizeable capital raised. The biggest risks remain the combination of negative equity, continued cash burn and the reliance on aggressive growth targets that the market had not previously priced in.

However, investors should be aware that Rezolve AI’s balance sheet position leaves little room for missteps. Rezolve AI's shares have been on the rise but are still potentially undervalued. Find out how large the opportunity might be.

Exploring Other Perspectives

Fifteen fair value estimates from the Simply Wall St Community span from almost zero to over US$12 per share, highlighting how far apart individual views are. Set against Rezolve AI’s much higher 2025 and 2026 revenue guidance, this gap in expectations underlines how differently investors may interpret execution risk, capital needs and the company’s ability to reach its ambitious targets.

Explore 15 other fair value estimates on Rezolve AI - why the stock might be worth over 3x more than the current price!

Build Your Own Rezolve AI Narrative

Disagree with this assessment? Create your own narrative in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Rezolve AI research is our analysis highlighting 2 key rewards and 4 important warning signs that could impact your investment decision.
• Our free Rezolve AI research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Rezolve AI's overall financial health at a glance.

Ready For A Different Approach?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• We've found 13 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.
• The end of cancer? These 29 emerging AI stocks are developing tech that will allow early identification of life changing diseases like cancer and Alzheimer's.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.